TABLE 2.
Improvement in Comorbidities
| OP Type (%: Preoperative Prevalence of Comorbidity) | Remission (%) | Improved (%) | Unchanged (%) | Worsened (%) | |
| Hypertension | LSG (63%) | 65.2 | 34.8 | 0.0 | 0.0 |
| LRYGB (59%) | 71.2 | 25.0 | 3.8 | 0.0 | |
| Dyslipidemia* | LSG (67%) | 43.8 | 35.4 | 16.7 | 4.1 |
| LRYGB (51%) | 71.7 | 26.1 | 2.2 | 0.0 | |
| T2DM | LSG (24%) | 60.0 | 35.0 | 0.0 | 5.0 |
| LRYGB (26%) | 77.0 | 23.0 | 0.0 | 0.0 | |
| OSAS | LSG (48%) | 90.2 | 9.8 | 0.0 | 0.0 |
| LRYGB (42%) | 82.2 | 17.8 | 0.0 | 0.0 | |
| Back/joint pain | LSG (61%) | 44.2 | 37.2 | 14.0 | 4.6 |
| LRYGB (68%) | 42.5 | 47.5 | 7.5 | 2.5 | |
| GERD† | LSG (44%) | 61.0 | 5.0 | 14.6 | 19.4 |
| LRYGB (46%) | 77.6 | 14.3 | 6.1 | 2.0 | |
| Hyperuricemia | LSG (15%) | 81.8 | 9.1 | 0.0 | 9.1 |
| LRYGB (10%) | 100 | 0.0 | 0.0 | 0.0 | |
| Depression | LSG (20%) | 26.7 | 40.0 | 33.3 | 0.0 |
| LRYGB (11%) | 33.4 | 22.2 | 44.4 | 0.0 |
Comparing improvement of comorbidities between the 2 groups, the only statistically significant differences seen were in remission of dyslipidemia (*) and worsening of preexisting GERD (†), where LRYGB was superior to LSG 3 years after surgery. In brakes: preoperative prevalence.